Is Another Heparin Crisis Looming? Congress Raises Alarm, Demands US FDA Briefing
05 Aug 2019
Biosimilar
The FDA must explain how it will prevent heparin adulteration as a virus kills pigs in China again.
Related Stories
Global Regulators Caution Against Misinformation On Biosimilars
The Stakes Are High So Get It Right: CHMP Oral Explanations & FDA AdComs
Keeping Track: Turalio, Nubeqa And Accrufer Mark Trio Of Novel Drug Approvals
Organizations
-Indications
-Targets
Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.